2-氨基-4-苯基-5-噻唑甲酸乙酯盐酸盐 | 53266-92-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 中文名称: 2-氨基-4-苯基-5-噻唑甲酸乙酯盐酸盐
• 中文别名: 2-氨基-4-甲基噻唑-5-甲酸乙酯盐酸盐；2-氨基-4-苯基-5-噻唑甲酸乙酯
• 英文名称: 2-amino-4-methyl-thiazole-5-carboxylic acid ethyl ester; hydrochloride
• 英文别名: 2-amino-4-methyl-thiazole-5-carboxylic acid ethyl ester; monohydrochloride；2-Amino-4-methyl-thiazol-5-carbonsaeure-aethylester; Monohydrochlorid；ethyl 2-amino-4-methylthiazole-5-carboxylate hydrochloride；ethyl 2-amino-4-methyl-1,3-thiazole-5-carboxylate;hydrochloride
• CAS: 53266-92-5
• 化学式: C₇H₁₀N₂O₂S*ClH
• mdl: MFCD00829075
• 分子量: 222.696
• InChiKey: DCTXAUJLGMDHAJ-UHFFFAOYSA-N

物化性质

• 熔点：
  216-217 °C (decomp)

计算性质

• 辛醇/水分配系数(LogP)：
  1.11
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.428
• 拓扑面积：
  93.4
• 氢给体数：
  2
• 氢受体数：
  5

安全信息

• 危险等级：
  IRRITANT
• 安全说明：
  S24/25
• 海关编码：
  2934100090

SDS

Name:	Ethyl 2-amino-4-methyl-1 3-thiazole-5-carboxylate hydrochloride tech Material Safety Data Sheet
Synonym:
CAS:	53266-92-5

Section 1 - Chemical Product MSDS Name:Ethyl 2-amino-4-methyl-1 3-thiazole-5-carboxylate hydrochloride tech Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
53266-92-5	Ethyl 2-amino-4-methyl-1,3-thiazole-5-		unlisted

Hazard Symbols: None Listed.
Risk Phrases: None Listed.

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Not available.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
May cause respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 53266-92-5: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 215 deg C(decom)
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C7H11ClN2O2S
Molecular Weight: 222.7

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Hydrogen chloride, chlorine, nitrogen oxides, carbon monoxide, oxides of sulfur, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 53266-92-5 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Ethyl 2-amino-4-methyl-1,3-thiazole-5-carboxylate hydrochloride - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 53266-92-5: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 53266-92-5 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 53266-92-5 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-氨基-4-苯基-5-噻唑甲酸乙酯盐酸盐 、 对氰基苯甲酰氯 在 盐酸 、 水 作用下， 以 吡啶 为溶剂， 反应 1.17h， 以to give ethyl 2-(4-cyanobenzoylamino)-4-methylthiazole-5-carboxylate (262.0 g)的产率得到ethyl 2-(4-cyanobenzoylamino)-4-methylthiazole-5-carboxylate
  参考文献：
  名称：

  Thiazoline derivatives

  摘要：

  一种噻唑啉衍生物，其化学式为：##STR1## [其中R.sup.1为氰基、氨基甲酰基、硫氨基甲酰基、吗啉硫氨基甲酰基、烷基硫代亚咪唑基、氨基亚胺基、取代氨基亚胺基或咪唑啉-2-基，R.sup.2为烷基或芳基烷基，R.sup.3为氢或烷基，R.sup.4为羟基、烷氧基、取代烷氧基或氨基，l为1至5的整数]及其盐具有纤维蛋白原受体拮抗和细胞黏附因子拮抗作用，并可用作缺血性疾病和动脉硬化疾病的治疗剂以及肿瘤转移抑制剂。

  公开号：

  US05478945A1

文献信息

• Imtiaz Husain; Nasir, Journal of the Indian Chemical Society, 1976, vol. 53, # 3, p. 305 - 306
  作者：Imtiaz Husain、Nasir

  DOI：——

  日期：——
• THIAZOLINE DERIVATIVE
  申请人：TAISHO PHARMACEUTICAL CO. LTD

  公开号：EP0649843B1

  公开（公告）日：2000-09-06
• US5478945A
  申请人：——

  公开号：US5478945A

  公开（公告）日：1995-12-26
• Thiazoline derivatives
  申请人：Taisho Pharmaceutical Co., Ltd.

  公开号：US05478945A1

  公开（公告）日：1995-12-26

  A thiazoline derivative represented by the formula: ##STR1## [wherein R.sup.1 is cyano, carbamoyl, thiocarbamoyl, morpholinothiocarbonyl, alkylthioimidoyl, amidino, substituted amidino or imidazolin-2-yl, R.sup.2 is alkyl or aralkyl, R.sup.3 is hydrogen or alkyl, R.sup.4 is hydroxyl, alkoxy, substituted alkoxy or amino, l is an integer of 1 to 5] and salts thereof have fibrinogen receptor antagonism and cell adhesion factor antagonism, and are useful as therapeutic agents for ischemic diseases and atherosclerosis diseases, and metastasis inhibitory agents of tumors.

  一种由以下公式表示的噻唑啉衍生物：##STR1## [其中R.sup.1为氰基，氨甲酰基，硫氨甲酰基，吗啉硫氨基甲酰基，烷基硫代亚胺基，胺基甲酰基，取代的胺基甲酰基或咪唑啉-2-基，R.sup.2为烷基或芳基烷基，R.sup.3为氢或烷基，R.sup.4为羟基，烷氧基，取代的烷氧基或氨基，l为1至5的整数]及其盐具有纤维蛋白原受体拮抗作用和细胞粘附因子拮抗作用，可用作缺血性疾病和动脉粥样硬化疾病的治疗剂，以及肿瘤的转移抑制剂。